NCT03311776 BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")
| NCT ID | NCT03311776 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Inna Chen, MD |
| Condition | Pancreatic Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2008-07-03 |
| Primary Completion | 2035-07-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2008-07-03 with a primary completion date of 2035-07-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
No validated biomarkers to identify PC at an early stage and to predict treatment outcomes in the individual patient exist. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.
Eligibility Criteria
Inclusion Criteria: * Age \> 18 years * Histologically verified PC (ductal adenocarcinoma) or ampullary adenocarcinoma in a resected specimen; or histopathological confirmation of carcinoma in patients not undergoing surgery in the setting of clinical and radiological characteristics which, together with the pathology, are consistent with a diagnosis of PC independently of stage Exclusion Criteria: • None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03311776 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Pancreatic Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03311776 currently recruiting?
Yes, NCT03311776 is actively recruiting participants. Contact the research team at Julia.Sidenius.Johansen@regionh.dk for enrollment information.
Where is the NCT03311776 trial being conducted?
This trial is being conducted at Herlev, Denmark.
Who is sponsoring the NCT03311776 clinical trial?
NCT03311776 is sponsored by Inna Chen, MD. The trial plans to enroll 5,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.